Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

Altri documenti

53695

Sigma-Aldrich

3-(Tritylthio)propionic acid

≥97.0% (T)

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula condensata:
(C6H5)3CSCH2CH2COOH
Numero CAS:
27144-18-9
Peso molecolare:
348.46
Numero MDL:
MFCD00237291
Codice UNSPSC:
12352100
ID PubChem:
57651432
NACRES:
NA.22

Livello qualitativo

100

Saggio

≥97.0% (T)

Stringa SMILE

OC(=O)CCSC(c1ccccc1)(c2ccccc2)c3ccccc3

InChI

1S/C22H20O2S/c23-21(24)16-17-25-22(18-10-4-1-5-11-18,19-12-6-2-7-13-19)20-14-8-3-9-15-20/h1-15H,16-17H2,(H,23,24)
AECGEIVNZGQBJT-UHFFFAOYSA-N

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302,H315,H319,H335,H413

Classi di pericolo

Acute Tox. 4 Oral - Aquatic Chronic 4 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Organi bersaglio

Respiratory system

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Dispositivi di protezione individuale

dust mask type N95 (US), Eyeshields, Gloves

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 4

1 of 4

L-Cysteic acid monohydrate ≥99.0% (T)

Sigma-Aldrich

30170

L-Cysteic acid monohydrate

2-[[(2-Carboxyethyl)sulfanylthiocarbonyl]-sulfanyl]propanoic acid

Sigma-Aldrich

900152

2-[[(2-Carboxyethyl)sulfanylthiocarbonyl]-sulfanyl]propanoic acid

Fmoc-Tyr(tBu)-OH ≥98.0% (HPLC)

Sigma-Aldrich

47623

Fmoc-Tyr(tBu)-OH

4-Pentynoic acid 95%

Sigma-Aldrich

232211

4-Pentynoic acid

Mathew R Schnorenberg et al.
ACS omega, 3(10), 14144-14150 (2018-11-10)
Despite the therapeutic promise of phospholipid-based nanocarriers, a major obstacle to their widespread clinical translation is a susceptibility to fatty acid ester hydrolysis, leading to lack of quality control and inconsistencies in self-assembly formulations. Using electrospray ionization mass spectrometry fragmentation
Naglaa Salem El-Sayed et al.
Molecules (Basel, Switzerland), 24(7) (2019-04-14)
Cell-penetrating peptide [WR]₅ has been previously shown to be an efficient molecular transporter for various hydrophilic and hydrophobic molecules. The peptide was synthesized using Fmoc/tBu solid-phase chemistry, and one arginine was replaced with one lysine to enable the conjugation with
Partha Laskar et al.
Nanoscale, 11(42), 20058-20071 (2019-10-16)
Combination therapy involving chemotherapeutic drugs and genes is emerging as a promising strategy to provide a synergistic therapeutic effect, to overcome drug resistance while reducing the severe side effects associated with conventional chemotherapeutic drugs. However, the lack of nanomedicines able
Scott H Medina et al.
Journal of controlled release : official journal of the Controlled Release Society, 209, 317-326 (2015-05-17)
Many lead molecules identified in drug discovery campaigns are eliminated from consideration due to poor solubility and low cell permeability. These orphaned molecules could have clinical value if solubilized and delivered properly. SVS-1 is a de novo designed peptide that

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.